Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06561438
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-17
Brief Title:
Postoperative Pain Management Following Laparoscopic Cholecystectomy
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Postoperative Pain Management Following Laparoscopic Cholecystectomy- Vortioxetine
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Postoperative pain management is essential and the inability to treat acute pain appropriately in the first 48 postoperative hours represents a risk factor for developing chronic pain No study has investigated Vortioxetine as an adjuvant to standard care for postoperative pain management in patients undergoing LC
Detailed Description:
Postoperative pain is a main challenge for delayed hospital discharge in Laparoscopic cholecystectomy Postoperative pain management is essential and the inability to treat acute pain appropriately in the first 48 postoperative hours represents a risk factor for developing chronic pain Vortioxetine VO is a multimodal serotonergic antidepressant with a unique mechanism of action that is effective in treating neuropathic pain The purpose of this study is evaluating the efficacy and tolerability of preoperative oral administration of Vortioxetine on postoperative pain control in patients undergoing LC
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None